Efficacy and safety of lizhi soft capsule in treatment of patients with beni gn prostatic hyperplasia
- VernacularTitle:力至软胶囊治疗良性前列腺增生症的临床研究
- Author:
Farong ZHANG
- Publication Type:Journal Article
- Keywords:
clinical trial;
the lizhi soft capsule;
the qianl iekang capsule;
benign prostatic hyperplasia;
traditional Chinese medicine
- From:
Chinese Journal of Clinical Pharmacology and Therapeutics
2004;0(12):-
- CountryChina
- Language:Chinese
-
Abstract:
AIM: To compare the efficacy and safety of the lizhi soft ca psule and the qianliekang capsule in the treatment of patients with benign prost atic hyperplasia. METHODS: The lizhi soft capsule was observed i n the randomized, double blind and double-dummy clinical trial. 101 patients wi th benign prostatic hyperplasia were radomly divided into two groups: 50 patient s were administered the lizhi soft capsule (trail group), while 51 patients were administered the qianliekang capsule (control group). Drugs were orally adminis tered with the same duration in the two groups. Scores of symptoms were recorded before and after the treatment in all of the patients. Curative effects were ev aluated with the different grades such as conspicuous, remission, middle, weak a nd inefficacy. RESULTS: The scores of symptoms significantly dec reased after the treatment in the two groups (P 0.05). No serious side effects were found in the two groups. CONCLUSION: Both the lizhi soft capsule and the qianliekang capsule ha ve the same efficacy and safety in the treatment of benign prostatic hyperplasia 。
